BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38627364)

  • 1. Differentiation shifts from a reversible to an irreversible heterochromatin state at the DM1 locus.
    Handal T; Juster S; Abu Diab M; Yanovsky-Dagan S; Zahdeh F; Aviel U; Sarel-Gallily R; Michael S; Bnaya E; Sebban S; Buganim Y; Drier Y; Mouly V; Kubicek S; van den Broek WJAA; Wansink DG; Epsztejn-Litman S; Eiges R
    Nat Commun; 2024 Apr; 15(1):3270. PubMed ID: 38627364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.
    Ueki J; Nakamori M; Nakamura M; Nishikawa M; Yoshida Y; Tanaka A; Morizane A; Kamon M; Araki T; Takahashi MP; Watanabe A; Inagaki N; Sakurai H
    Sci Rep; 2017 Feb; 7():42522. PubMed ID: 28211918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering the Role of Hypermethylation by CTG Expansion in Myotonic Dystrophy Type 1 Using Mutant Human Embryonic Stem Cells.
    Yanovsky-Dagan S; Avitzour M; Altarescu G; Renbaum P; Eldar-Geva T; Schonberger O; Mitrani-Rosenbaum S; Levy-Lahad E; Birnbaum RY; Gepstein L; Epsztejn-Litman S; Eiges R
    Stem Cell Reports; 2015 Aug; 5(2):221-31. PubMed ID: 26190529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's and myotonic dystrophy hESCs: down-regulated trinucleotide repeat instability and mismatch repair machinery expression upon differentiation.
    Seriola A; Spits C; Simard JP; Hilven P; Haentjens P; Pearson CE; Sermon K
    Hum Mol Genet; 2011 Jan; 20(1):176-85. PubMed ID: 20935170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)
    André LM; van Cruchten RTP; Willemse M; Bezstarosti K; Demmers JAA; van Agtmaal EL; Wansink DG; Wieringa B
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-Induced (CTG⋅CAG)
    van Agtmaal EL; André LM; Willemse M; Cumming SA; van Kessel IDG; van den Broek WJAA; Gourdon G; Furling D; Mouly V; Monckton DG; Wansink DG; Wieringa B
    Mol Ther; 2017 Jan; 25(1):24-43. PubMed ID: 28129118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotonic dystrophy type 1 embryonic stem cells show decreased myogenic potential, increased CpG methylation at the DMPK locus and RNA mis-splicing.
    Franck S; Couvreu De Deckersberg E; Bubenik JL; Markouli C; Barbé L; Allemeersch J; Hilven P; Duqué G; Swanson MS; Gheldof A; Spits C; Sermon KD
    Biol Open; 2022 Jan; 11(1):. PubMed ID: 35019138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues.
    López Castel A; Nakamori M; Tomé S; Chitayat D; Gourdon G; Thornton CA; Pearson CE
    Hum Mol Genet; 2011 Jan; 20(1):1-15. PubMed ID: 21044947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MSH2 knock-down shows CTG repeat stability and concomitant upstream demethylation at the DMPK locus in myotonic dystrophy type 1 human embryonic stem cells.
    Franck S; Barbé L; Ardui S; De Vlaeminck Y; Allemeersch J; Dziedzicka D; Spits C; Vanroye F; Hilven P; Duqué G; Vermeesch JR; Gheldof A; Sermon K
    Hum Mol Genet; 2021 Jan; 29(21):3566-3577. PubMed ID: 33242073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
    Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the Complex Relationship between Epigenetics Markers, CTG Repeat Instability and Symptoms in Myotonic Dystrophy Type 1.
    de Pontual L; Tomé S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.
    Dastidar S; Ardui S; Singh K; Majumdar D; Nair N; Fu Y; Reyon D; Samara E; Gerli MFM; Klein AF; De Schrijver W; Tipanee J; Seneca S; Tulalamba W; Wang H; Chai YC; In't Veld P; Furling D; Tedesco FS; Vermeesch JR; Joung JK; Chuah MK; VandenDriessche T
    Nucleic Acids Res; 2018 Sep; 46(16):8275-8298. PubMed ID: 29947794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent.
    Morales F; Corrales E; Zhang B; Vásquez M; Santamaría-Ulloa C; Quesada H; Sirito M; Estecio MR; Monckton DG; Krahe R
    Hum Mol Genet; 2021 Dec; 31(2):262-274. PubMed ID: 34432028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of congenital myotonic dystrophy.
    Lanni S; Pearson CE
    Neurobiol Dis; 2019 Dec; 132():104533. PubMed ID: 31326502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy.
    Barbé L; Lanni S; López-Castel A; Franck S; Spits C; Keymolen K; Seneca S; Tomé S; Miron I; Letourneau J; Liang M; Choufani S; Weksberg R; Wilson MD; Sedlacek Z; Gagnon C; Musova Z; Chitayat D; Shannon P; Mathieu J; Sermon K; Pearson CE
    Am J Hum Genet; 2017 Mar; 100(3):488-505. PubMed ID: 28257691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
    Langlois MA; Lee NS; Rossi JJ; Puymirat J
    Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Visconti VV; Macrì E; D'Apice MR; Centofanti F; Massa R; Novelli G; Botta A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust Detection of Somatic Mosaicism and Repeat Interruptions by Long-Read Targeted Sequencing in Myotonic Dystrophy Type 1.
    Mangin A; de Pontual L; Tsai YC; Monteil L; Nizon M; Boisseau P; Mercier S; Ziegle J; Harting J; Heiner C; Gourdon G; Tomé S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
    Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
    FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.
    Furling D; Lemieux D; Taneja K; Puymirat J
    Neuromuscul Disord; 2001 Nov; 11(8):728-35. PubMed ID: 11595515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.